Healthtech Startups

Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.

1 investor

Love Ur Curls develops and sells personalized curl-care hair products, primarily through a 3-step system tailored for different hair types and styling goals. The company serves consumers seeking simpler, science-based alternatives to complex curly hair routines.

1 investor

Cynosure Lutronic develops laser and radiofrequency (RF) medical devices for aesthetic and gynecologic treatments, including its XERF RF treatment. Its products are sold to practitioners, physicians, and aesthetic practice owners to expand their treatment offerings.

1 investor

LUWI is a women-led company developing sexual healthcare products, with a focus on contraception designed around pleasure. Its main product, LUWI Finer Liner, is a hormone-free, latex-free contraceptive intended to prevent STIs while preserving sensation.

1 investor

LUX Infusion provides clinical infusion therapy for patients with complex and chronic conditions, including immune deficiencies, autoimmune and inflammatory conditions, transplant immunosuppression, and bleeding disorders. It delivers care at home or at its infusion locations and manages insurance approvals, prior authorizations, and medication delivery for patients.

1 investor

LUX MED operates a network of private medical facilities in Poland, offering diagnostic imaging (MRI, CT, mammography, ultrasound, X-ray), laboratory testing, specialist physician consultations, and optical salons. It serves patients seeking outpatient healthcare and provides urgent medical assistance around the clock.

1 investor

LuxCreo offers an in-house 3D printing ecosystem for dental practices, combining printers, curing and washing hardware, resins, and software to produce direct-print clear aligners and other dental devices. Its workflow removes the model and thermoforming steps and includes an FDA Class II 510(k)-cleared direct-print aligner process for orthodontics, prosthodontics, and restorative dentistry.

1 investor

LVED provides a digital platform for creating, managing, and executing estate plans with secure storage for legal documents, digital assets, and final messages. The platform serves individuals seeking to organize and transfer their financial, emotional, and digital legacies to designated beneficiaries.

1 investor

LVIS provides a cloud-based EEG software platform that enables hospitals to access and collaborate on neurological diagnostic data from multiple EEG systems through a single vendor-agnostic interface, reducing reliance on proprietary local software and IT infrastructure.

1 investor

LXE Hearing is the parent company of hearing-technology brands Eargo, Lexie Hearing, and hearX, offering direct-to-consumer and over-the-counter hearing aids plus tools for detecting and diagnosing hearing loss. The company has begun winding down its US operations.

1 investor

Lydus Medical develops surgical devices for anastomosis procedures in microsurgery, combining clinical insight with engineering to make these operations faster and more reliable. The company was founded within Sanara Ventures based on a clinical need identified in the microsurgery operating room.

1 investor

LyfeMD is a virtual clinic offering personalized, evidence-based guidance on nutrition, mental wellness, and movement for patients managing IBD (Crohn's/colitis) and inflammatory arthritis. It provides nutrition planning, mental wellness support, health coaching, and patient education to complement patients' existing medical treatment.

1 investor

LyfPlus provides digital health solutions for hospitals, helping them optimize operations and improve service quality by modernizing paper-based health infrastructure.

1 investor

LyGenesis is a clinical-stage cell therapy company that uses a patient's own lymph nodes as bioreactors to grow functioning ectopic organs. Its allogeneic cell therapies target diseases including end stage liver disease, end stage renal disease, Type 1 diabetes, and aging of the thymus.

1 investor

LymphaTouch is a Finnish health technology company that manufactures a medical device combining negative pressure and mechanical vibration for manual therapy applications including edema management, soft tissue mobilization, scar therapy, and pain management.

1 investor

Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.

1 investor

Lynd Clinical operates a network of clinical research sites in underserved rural and community markets, using technology and local partnerships to expand patient access to clinical trials. The company combines on-the-ground site development with AI-enabled infrastructure to make research populations more representative and accessible to pharmaceutical sponsors.

1 investor

Latica provides a secure platform for accessing and analyzing real-world structured and unstructured patient data across the patient journey, including images, physician notes, and video. It serves specialty medicine practices, medtech companies, and life science organizations to support clinical research, AI model development, and data collaboration.

1 investor

Lynx Dx develops MyProstateScore 2.0 (MPS2), a urine test that analyzes 18 gene transcripts to predict the presence of clinically significant prostate cancer. The diagnostic can be run as a biomarker-only test or combined with clinical risk factors, generating individualized patient reports for healthcare providers.

1 investor

Lynxight connects standard security cameras to an AI system that detects drowning risks and safety incidents at commercial pools, sending alerts to lifeguards via smartwatches and workstations. It serves pool operators for both lifeguard-attended and remotely supervised pools, and operates in 16 countries.

1 investor

Lyra Therapeutics develops biocompatible mesh scaffolds for sustained drug delivery to the sinonasal passages, targeting treatment of chronic rhinosinusitis. The company's proprietary platform uses bioabsorbable polymers and engineered matrices to deliver medication over up to six months with a single administration.

1 investor

Lyrica is a pharmaceutical product used to manage fibromyalgia, a chronic condition characterized by widespread pain and fatigue. The page provides patient education about fibromyalgia symptoms and treatment options including medication, self-care, and exercise.

1 investor

Lysol is a consumer disinfecting product brand that manufactures cleaning wipes for use on household and commercial surfaces. The company operates in the consumer health and cleaning products category.

1 investor

Lyterian Therapeutics develops pharmaceutical treatments by leveraging protein homeostatic mechanisms to target genetically-validated disease drivers. The company focuses on transformative medicines for patients across multiple disease areas.

1 investor